Full Press Release Details
Regeneron Announces Positive Primary Endpoint Results from a Phase 2 Study of VEGF Trap-Eye in Age-related Macular Degeneration Data presented at Retina Society Conference in Boston.
REGN
Regeneron Announces Positive Primary Endpoint Results from a Phase 2 Study of VEGF Trap-Eye in Age-related Macular Degeneration Data presented at Retina Society Conference in Boston
Key Takeaway: Regeneron Announces Positive Primary Endpoint Results from a Phase 2 Study of VEGF Trap-Eye in Age-related Macular Degeneration Data presented at Retina Society Conference in Boston